drugset / Trial / NCT02677051

Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

NCT02677051

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a double blind treatment trial that will test if sulforaphane improves core symptoms in autism. The investigators expect to see clinical improvement in some of these areas. Sulforaphanes come from eating certain vegetables such as broccoli. The investigators will be using a preparation that gives specific and reproducible amounts. The investigators will also test specific chemicals and genes needed for sulforaphane usage to try to understand differences in response.

Timeline

Start
2016-02
Primary completion
2025-12
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulforaphane Small molecule 0.05 mmol
Subject Sulforaphane Small molecule 0.1 mmol
Subject Sulforaphane Small molecule 0.15 mmol

Indications